When CV-1 cells expressing haemagglutinin (HA) 
The major glycoprotein of influenza virus, the haemagglutinin (HA), has to undergo proteolytic cleavage in order to be fully functional. Uncleaved HA is able to mediate virus attachment but it cannot perform the fusion step necessary for the initiation of infection. With some avian influenza viruses belonging to serotypes H5 and H7, HA is cleaved at a multibasic cleavage site by furin or other subtilisin-like endoproteases. Since these proteases are trans-Golgi network (TGN) constituents present in all cells, such HAs are always synthesized in the cleaved form. However, the HAs of the other strains (including all human influenza viruses) are cleaved at monobasic cleavage sites by specific proteases produced by some secretory cells (for review see Klenk & Garten, 1994) . In cell cultures such strains usually need the presence of trypsin or a trypsin-like enzyme in the medium for cleavage of HA. The use of trypsin as a component of maintenance medium ensuring efficient HA activation and allowing the progress of multi-cycle infection has therefore provided a powerful tool for studies on human influenza viruses. However, the application of trypsin also has its limitations. For largescale virus production (e.g. vaccine production in cell cultures) the use of expensive crystalline enzyme preparations is not feasible. Besides, in some cell cultures a loss of trypsin activity has been demonstrated (Kaverin & Webster, 1995) . A possible way to circumvent the necessity for trypsin might be the introduction of highly cleavable HA, as occurring with subtypes H5 and H7, into virions by phenotypic mixing. Phenotypic mixing was first described over 40 years ago for influenza viruses (Hirst & Gotlieb, 1953) and later thoroughly studied with several other enveloped viruses, especially vesicular stomatitis virus (for review see Weiss, 1981) . In recent years the development of vector-mediated expression systems has made it possible to study phenotypic mixing under more defined conditions. Recently, Naim & Roth (1993) showed that CV-1 cells expressing HA of the H2 subtype from an SV40 vector produce phenotypically mixed virions when superinfected with influenza A virus belonging to another serotype. We now demonstrate that phenotypic mixing with highly cleavable HA expressed from an SV40 vector allows multi-cycle replication of influenza virus A/FM/1/47 (FM1) in cells which normally are unable to activate this virus.
When CV-1 cells infected with FM1 virus were incubated without trypsin (Fig. 1 a) Haemadsorbing centre assays were carried out in CV-1 cells grown in Falcon 6-well plates. Infectivity was expressed as the number of haemadsorbing centres/ml of undiluted virus stock solution (Boycott et aL, 1994) . To determine growth curves, cells were washed three times with DMEM prior to infection, overlaid with virus dilutions prepared in DMEM with 0.2% BSA, incubated for 1 h at 37 °C, again washed three times with DMEM, and incubated with DMEM supplemented with 0.2 % BSA for the times indicated. Virus yields were determined in the culture fluid by haemagglutination titration. Eighteen h after superinfection, progeny virus was collected with the media and treated with TPCK-trypsin (3 gg/ml for 1 h at 37 °C) or mock treated. Infectivity was measured by the haemadsorbing cell count assay, and the percentage of infectious progeny virus was calculated as described in the text. superinfected with FM1 virus. The cells were infected with the H7-SV40 recombinant at a dose that allowed 60 70 % of the cells to produce H7 antigen 60 h p.i. (as measured by immunofluorescent staining). At different time intervals, the cells were superinfected with h u m a n influenza virus at an m.o.i, of 5-0 as determined by haemadsorbing cell count titration. After 18 h incubation, progeny virus was harvested and treated with T P C Ktrypsin. Trypsin-treated and mock-treated samples were titrated by counting haemadsorbing cells in CV-1 cell cultures. The percentage o f infectious progeny virus was calculated as P = (I1/I2) x 100, where I1 is the infectious titre in the mock-treated sample, I2 is the infectious titre in the trypsin-treated sample and P is the percentage of the infectious virus in the yield. Only 0.2-0.4 % of the FM1 progeny virus was infectious when replication occurred in cells not expressing H7 H A (Fig.  2) . When H7 H A was expressed, the amount of infectious virus increased more than 20-fold as a function of time. To further prove the concept that the increase in virus infectivity was the result of phenotypic mixing with H7 HA, an attempt was made to neutralize the infectivity with anti-influenza A / F P V / 3 4 / R o s t o c k ( H 7 ) (FPV) serum. Virus collected from cells preinfected with the H7-SV40 recombinant was treated with polyclonal rabbit anti-FPV serum. This treatment resulted in a 30-to 50-fold decrease in infectivity, whereas treatment with preimmune serum had no effect (data not shown).
Finally, the structural proteins of progeny virus have been analysed by SDS P A G E and Western blotting ( Harvested culture fluids were clarified by centrifugation at 4000 r.p.m, for 30 min and the virus was pelleted by centrifugation at 72000g for 1 h at 4 °C. Pellets were resuspended in PBS and debris which could not be suspended was removed by centrifugation at 5000 r.p.m, for 3 min in a microcentrifuge. The virus was concentrated by centrifugation at 40000 g for 1 h at 4 °C and resuspended in 0.1 ml PBS. Pelleted virus was subjected to SDS-PAGE. Viral proteins were monitored by Western blotting using rabbit antisera raised against FPV virions (lanes 1, 2 and 3) or against the glycoproteins of strain A/PR/8/34(H1N1) (lanes 4, 5 and 6) and an enhanced chemiluminescence detection kit (Amersham). Lanes l and 4, virus obtained from FMl-infected cells; lanes 2 and 5, virus obtained from H7 expressing cells superinfected with FM 1 virus; lanes 3 and 6, material pelleted from supernatant of H7 expressing cells.
3). Analysis of FM1 virions obtained from cells not expressing H7 HA revealed the presence of nucleocapsid protein (NP) and matrix protein (M1) when a typespecific antiserum raised against total FPV was used (lane 1) and the presence of uncleaved HA and neuraminidase (NA), when an antiserum specific for FM1 glycoproteins was used (lane 4). Virions obtained from cells infected with both the H7-SV40 recombinant and FM1 contained cleaved FPV HA (lane 2), in addition to uncleaved FM1 HA (lane 5). Cells infected with the SV40 recombinant alone did not produce virus particles (lanes 3 and 6). Thus, under conditions of phenotypic mixing cleaved HA could be clearly demonstrated in virus particles. The amount of cleaved H7 HA present in H 1 particles is difficult to determine. Cleaved HA could be detected in such preparations only by immunoblotting. However, we failed to detect it by fluorography after labelling with [aSS]methionine. One can therefore assume that the amount of cleaved HA in total virus obtained from transfected cells is not higher than 1%. Since the proportion of infectious virions was usually below 10 % in these preparations, it is presumably sufficient to render a virus particle infectious if 10 % of its HA molecules are cleaved.
The effect of phenotypic mixing on multi-cycle replication has also been analysed. CV-1 cells were preinfected with the H7-SV40 recombinant vector or with a non-expressing SV40 recombinant as a control. Optimal expression of H7 HA was obtained over a relatively broad range of vector concentrations used for inoculation. Expression and control vectors were used at equal concentrations. Twenty-four h after infection with the vectors, the cells were superinfected with FM 1 virus at an m.o.i, of 0"01. A typical multi-cycle growth curve was observed when cells expressed H7 HA, whereas no virus could be detected in the absence of H7 HA expression (Fig. 4a) . The data show that vectorexpressed H7 HA is incorporated into the progeny virions of the superinfecting human influenza virus in a functional state and also that M2 of FM1 virus can substitute for the FPV M2 which is necessary to protect the H7 HA from acid denaturation in the TGN . H7 HA could be stabilized not only with M2 of FPV but also with M2 of PR/8 (unpublished data).
To further substantiate the concept that the inability of tissue culture cells to produce human influenza virus strains in infectious form can be overcome by expression of an HA susceptible to furin, a mutant of the A/Port Chalmers/1/73(H3) HA with an insertion of four arginine residues at the cleavage site (I4 +) has been used for phenotypic mixing with FM1 virus. We have previously shown that, unlike wild-type H3 HA containing a single arginine at the cleavage site, mutant I4 + is activated in CV-1 cells (Ohuchi et aI., 1991) . After preinfection with SV40 recombinants expressing either the I4+ mutant or wild-type H3 HA, CV-1 cells were superinfected with FM1 virus at an m.o.i, of 0-01, i.e. under multi-cycle growth conditions. As can be seen in Fig. 4(b) , virus production was observed in cells expressing the I4 + mutant, but not in cells expressing wild-type H3 HA. These results clearly demonstrate that infectivity of FM1 virus depends exclusively on the cleavability of the heterologous HA used for phenotypic mixing.
The ability of the phenotypically mixed virus to initiate infection enables human influenza viruses to undergo multiple replication cycles in cell culture cells in the absence of trypsin. (Ohuchi et al., 1991) . Of the stock solution 40 lal (*), 20 ~tl (z~) and 10 lal (C)) was used. Cells were also infected with the non-expressing control recombinant (IS]). Twenty-four h after infection with the SV40 recombinants, cells were superinfected with FM1 at an m.o.i, of 0.01. Virus yields were determined by haemagglutination assay of the supernatants at the times indicated. may have practical applications. All influenza vaccines now in use are produced in embryonated chicken eggs. This mode of production has several disadvantages, such as antigenic variation and selection (Schild et al., 1983) and reduced efficacy as a vaccine (Kodihalli et al., 1995) resulting from egg passage and the difficulties connected with the increase of production in case of emergency. The use of cell cultures for influenza virus production, on the other hand, is hampered by the necessity to use several expensive components, among them crystalline trypsin. Moreover, it has been shown that at a high cell/volume ratio trypsin is inactivated (Kaverin & Webster, 1995) , resulting in the cessation of multi-cycle replication. The observation that infectious virus is obtained after expression of H3 HA adapted to furin cleavage is of particular interest, since phenotypically mixed virus containing only human HA appears to be well suited as a human vaccine. Obviously, SV40-based vectors cannot be used for vaccine production. However, cell lines permanently expressing highly cleavable HA should meet this requirement. Such lines are at present being developed.
